Julie Vincent

6.4k total citations · 1 hit paper
78 papers, 3.3k citations indexed

About

Julie Vincent is a scholar working on Epidemiology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Julie Vincent has authored 78 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Epidemiology, 26 papers in Cardiology and Cardiovascular Medicine and 26 papers in Oncology. Recurrent topics in Julie Vincent's work include Congenital Heart Disease Studies (25 papers), Colorectal Cancer Treatments and Studies (14 papers) and Cancer Treatment and Pharmacology (12 papers). Julie Vincent is often cited by papers focused on Congenital Heart Disease Studies (25 papers), Colorectal Cancer Treatments and Studies (14 papers) and Cancer Treatment and Pharmacology (12 papers). Julie Vincent collaborates with scholars based in France, United States and Japan. Julie Vincent's co-authors include François Ghiringhelli, Sylvain Ladoire, Lionel Apétoh, Cédric Rébé, Grégoire Mignot, Mélanie Bruchard, Fanny Chalmin, François Martin, Angélique Chevriaux and Valentin Dérangère and has published in prestigious journals such as Circulation, Immunity and Journal of the American College of Cardiology.

In The Last Decade

Julie Vincent

76 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell–Dependent Antitumor Immunity

2010 969 citations Julie Vincent, Grégoire Mignot et al. Cancer Research profile →

Peers

Julie Vincent

ONCOL

IMMUN

EPIDE

PRM

SURGE

James B. Whitmore United States

Hans‐Joachim Stemmler Germany

Camillo Ribi Switzerland

Hiroyasu Yokomise Japan

Toshiaki Morikawa Japan

Peter I. Bonta Netherlands

Nicole A. Aqui United States

Petri Koskinen Finland

Vincent Audard France

Frank Lehner Germany

James B. Whitmore United States

Julie Vincent

817 ×0.6

ONCOL

1.5k ×1.3

IMMUN

191 ×0.2

EPIDE

726 ×0.9

PRM

466 ×0.7

SURGE

Citations per year, relative to Julie Vincent Julie Vincent (= 1×) peers James B. Whitmore

Countries citing papers authored by Julie Vincent

Since Specialization

Citations

This map shows the geographic impact of Julie Vincent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Vincent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Vincent more than expected).

Fields of papers citing papers by Julie Vincent

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Vincent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Vincent. The network helps show where Julie Vincent may publish in the future.

Co-authorship network of co-authors of Julie Vincent

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Vincent. A scholar is included among the top collaborators of Julie Vincent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Vincent. Julie Vincent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bertaut, Aurélie, Alice Hervieu, Sylvie Zanetta, et al.. (2025). FOLFIRINOX-3 plus bevacizumab (bFOLFIRINOX3) in chemo-refractory metastatic colorectal cancer: a multicenter phase II trial. Future Oncology. 21(6). 699–706. 3 indexed citations

Ghiringhelli, François, et al.. (2022). Efficacy of Chemotherapy Plus Bevacizumab in Recurrent Glioblastoma Multiform: A Real-life Study. Anticancer Research. 42(12). 5847–5858. 5 indexed citations

Orry, David, J. Fraisse, Julie Vincent, et al.. (2019). Safety and efficacy of a docetaxel-5FU-oxaliplatin regimen with or without trastuzumab in neoadjuvant treatment of localized gastric or gastroesophageal junction cancer: A retrospective study. World Journal of Gastrointestinal Oncology. 11(8). 634–641. 1 indexed citations

Loffroy, Romaric, Nicolas Falvo, Motoki Nakaï, et al.. (2019). Partial splenic embolization with Glubran®2/Lipiodol® mixture for oncological patients with hypersplenism-related thrombocytopenia requiring systemic chemotherapy. Quantitative Imaging in Medicine and Surgery. 9(3). 409–417. 3 indexed citations

Ghiringhelli, François, Julie Vincent, Leila Bengrine, et al.. (2019). Hepatic arterial chemotherapy with raltitrexed and oxaliplatin versus standard chemotherapy in unresectable liver metastases from colorectal cancer after conventional chemotherapy failure (HEARTO): a randomized phase-II study. Journal of Cancer Research and Clinical Oncology. 145(9). 2357–2363. 18 indexed citations

Brembilla-Perrot, Béatrice, Julie Vincent, Arnaud Olivier, et al.. (2018). Does the age of evaluation change the long-term follow-up of untreated pre-excitation syndrome?. Journal of Electrocardiology. 51(5). 792–797. 2 indexed citations

Dubin, Anne M., Edward P. Walsh, Wayne H. Franklin, et al.. (2015). Task Force 4: Pediatric Cardiology Fellowship Training in Electrophysiology. Journal of the American College of Cardiology. 66(6). 706–711. 5 indexed citations

Ross, Robert D., Michael M. Brook, Peter Koenig, et al.. (2015). 2015 SPCTPD/ACC/AAP/AHA Training Guidelines for Pediatric Cardiology Fellowship Programs (Revision of the 2005 Training Guidelines for Pediatric Cardiology Fellowship Programs): Introduction. Journal of the American College of Cardiology. 66(6). 672–676. 8 indexed citations

Vincent, Julie, C. Mariette, Denis Pezet, et al.. (2015). Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Analysis of the non-randomised patients in FFCD 9102 phase III trial: Chemoradiation followed by surgery versus chemoradiation alone. European Journal of Cancer. 51(13). 1683–1693. 37 indexed citations

10.

Chai, Paul J., Isaac George, Tamim Nazif, et al.. (2015). Use of stented bovine pericardial valve for surgical mitral valve replacement in infants. Journal of Thoracic and Cardiovascular Surgery. 151(3). e51–e52. 9 indexed citations

11.

Zuckerman, Warren A., Mariel E. Turner, Alejandro Torres, et al.. (2013). Safety of Cardiac Catheterization at a Center Specializing in the Care of Patients with Pulmonary Arterial Hypertension. Pulmonary Circulation. 3(4). 831–839. 41 indexed citations

12.

Anderson, Brett R., Adam Ciarleglio, Denise A. Hayes, et al.. (2013). Earlier Arterial Switch Operation Improves Outcomes and Reduces Costs for Neonates With Transposition of the Great Arteries. Journal of the American College of Cardiology. 63(5). 481–487. 81 indexed citations

13.

Daly, Kevin P., Audrey C. Marshall, Julie Vincent, et al.. (2011). Endomyocardial biopsy and selective coronary angiography are low-risk procedures in pediatric heart transplant recipients: Results of a multicenter experience. The Journal of Heart and Lung Transplantation. 31(4). 398–409. 50 indexed citations

14.

Bergersen, Lisa, Kimberlee Gauvreau, Susan Foerster, et al.. (2011). Catheterization for Congenital Heart Disease Adjustment for Risk Method (CHARM). JACC: Cardiovascular Interventions. 4(9). 1037–1046. 115 indexed citations

15.

Vincent, Julie, Grégoire Mignot, Fanny Chalmin, et al.. (2010). 5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell–Dependent Antitumor Immunity. Cancer Research. 70(8). 3052–3061. 969 indexed citations breakdown →

16.

Bergersen, Lisa, Audrey C. Marshall, Kimberlee Gauvreau, et al.. (2009). Adverse event rates in congenital cardiac catheterization — A multi‐center experience. Catheterization and Cardiovascular Interventions. 75(3). 389–400. 151 indexed citations

17.

L’Ecuyer, Thomas J., Janet Poulik, & Julie Vincent. (2001). Myocardial Infarction Due to Coronary Abnormalities in Pulmonary Atresia with Intact Ventricular Septum. Pediatric Cardiology. 22(1). 68–70. 8 indexed citations

18.

Grifka, Ronald G., Charles E. Mullins, Julie Vincent, et al.. (1996). Initial clinical experience using the Gianturco-Grifka vascular occlusion device for congenital heart defects. Journal of the American College of Cardiology. 27(2). 118–119. 7 indexed citations

19.

Vincent, Julie, et al.. (1993). Acute changes in endothelin-1 after hemodialysis for chronic renal failure. The Journal of Pediatrics. 122(6). S74–S76. 16 indexed citations

20.

Steinseifer, Ulrich, et al.. (1989). Jamming of Prosthetic Heart Valves by Suture Trapping: Experimental Findings. The Thoracic and Cardiovascular Surgeon. 37(5). 288–293. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact